XML 29 R23.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders' Equity (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Equity [Abstract] |
Summary of Common Stock Shares Activity | The following table summarizes common stock share activity for the three and six months ended June 30, 2024 and 2023 (dollars in thousands):
|  | Three Months Ended June 30, 2024 |
|  | Shares of Common Stock |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Deficit |  |  | Total Stockholders’ Equity |
Balance, March 31, 2024 |  |  | 37,779,796 |  |  | $ | 41 |  |  | $ | 428,900 |  |  | $ | (354,836 | ) |  | $ | 74,105 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (14,458 | ) |  |  | (14,458 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 759 |  |  |  | — |  |  |  | 759 |
Common stock issued for vested restricted stock units |  |  | 76,667 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Balance, June 30, 2024 |  |  | 37,856,463 |  |  | $ | 41 |  |  | $ | 429,659 |  |  | $ | (369,294 | ) |  | $ | 60,406 |
|  | Three Months Ended June 30, 2023 |
|  | Shares of Common Stock |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Deficit |  |  | Total Stockholders’ (Deficit) Equity |
Balance, March 31, 2023 |  |  | 33,327,627 |  |  | $ | 36 |  |  | $ | 426,214 |  |  | $ | (456,164 | ) |  | $ | (29,914 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 122,260 |  |  |  | 122,260 |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 728 |  |  |  | — |  |  |  | 728 |
Common stock issued, net of expenses |  |  | 3,787,400 |  |  |  | 4 |  |  |  | — |  |  |  | — |  |  |  | 4 |
Common stock issued for vested restricted stock units |  |  | 60,638 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Balance, June 30, 2023 |  |  | 37,175,665 |  |  | $ | 40 |  |  | $ | 426,942 |  |  | $ | (333,904 | ) |  | $ | 93,078 |
|  | Six Months Ended June 30, 2024 |
|  | Shares of Common Stock |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Deficit |  |  | Total Stockholders’ Equity |
Balance, December 31, 2023 |  |  | 37,207,799 |  |  | $ | 40 |  |  | $ | 428,169 |  |  | $ | (355,247 | ) |  | $ | 72,962 |
Net loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (14,047 | ) |  |  | (14,047 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 1,464 |  |  |  | — |  |  |  | 1,464 |
Common stock issued through employee stock purchase plan |  |  | 18,815 |  |  |  | — |  |  |  | 26 |  |  |  | — |  |  |  | 26 |
Common stock issued for vested restricted stock units |  |  | 629,849 |  |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 1 |
Balance, June 30, 2024 |  |  | 37,856,463 |  |  | $ | 41 |  |  | $ | 429,659 |  |  | $ | (369,294 | ) |  | $ | 60,406 |
|  | Six Months Ended June 30, 2023 |
|  | Shares of Common Stock |  |  | Common Stock |  |  | Additional Paid-in Capital |  |  | Accumulated Deficit |  |  | Total Stockholders’ Equity |
Balance, December 31, 2022 |  |  | 32,682,342 |  |  | $ | 36 |  |  | $ | 425,485 |  |  | $ | (422,288 | ) |  | $ | 3,233 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 88,384 |  |  |  | 88,384 |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 1,435 |  |  |  | — |  |  |  | 1,435 |
Common stock issued through employee stock purchase plan |  |  | 2,662 |  |  |  | — |  |  |  | 4 |  |  |  | — |  |  |  | 4 |
Common stock issued, net of expenses |  |  | 4,150,400 |  |  |  | 4 |  |  |  | — |  |  |  | — |  |  |  | 4 |
Common stock issued for vested restricted stock units |  |  | 340,261 |  |  |  | — |  |  |  | 18 |  |  |  | — |  |  |  | 18 |
Balance, June 30, 2023 |  |  | 37,175,665 |  |  | $ | 40 |  |  | $ | 426,942 |  |  | $ | (333,904 | ) |  | $ | 93,078 |
Common Stock Reserved For Future Issuances | The Company had reserved shares of common stock for future issuance as follows:
|  | June 30, 2024 |  |  | December 31, 2023 |
Outstanding stock options |  |  | 2,842,808 |  |  |  | 1,867,795 |
Outstanding restricted stock units |  |  | 3,263,345 |  |  |  | 1,886,374 |
Warrants to purchase common stock associated with December 2020 public offering - Series 2 |  |  | — |  |  |  | 6,800,000 |
Prefunded warrants to purchase common stock associated with December 2020 public offering |  |  | 3,200,000 |  |  |  | 3,200,000 |
Warrants to purchase common stock associated with April 2022 public offering |  |  | 15,000,000 |  |  |  | 15,000,000 |
Prefunded warrants to purchase common stock associated with April 2022 public offering |  |  | 7,516,267 |  |  |  | 7,516,267 |
Warrants to purchase common stock associated with Loan Agreement |  |  | 198,811 |  |  |  | 198,811 |
Warrant to purchase common stock associated with Danforth |  |  | 50,000 |  |  |  | 50,000 |
For possible future issuance for the conversion of the March 2019 Notes |  |  | 1,138,200 |  |  |  | 1,138,200 |
For possible future issuance under 2024 Plan (Note 9) |  |  | 5,874,196 |  |  |  | 848,202 |
For possible future issuance under employee stock purchase plan |  |  | 1,458,171 |  |  |  | 1,474,045 |
For possible future issuance under 2015 Plan (Note 9) |  |  | 637,050 |  |  |  | 633,590 |
Total common shares reserved for future issuance |  |  | 41,178,848 |  |  |  | 40,613,284 |

X
- Definition Common stock reserved for future issuances. + References No definition available. + Details
Name: | scyx_CommonStockReservedForFutureIssuancesTableTableTextBlock
Namespace Prefix: | scyx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration